science

Scientific Review Committee

The SRC reviews applicable clinical research proposals to ensure that they meet an acceptable standard of scientific rigor and merit prior to IRB review.

The Scientific Review Committee (SRC) was established to reinforce the institutional mission of promoting research excellence. The SRC will review applicable clinical research proposals to ensure that they meet an acceptable standard of scientific rigor and merit prior to IRB review.

The SRC meets on the 1st and 3rd Tuesdays of each month. Studies must be submitted to the IRB office at least one week in advance of a meeting to be considered for the next SRC agenda.

Procedures

Criteria for Protocol Selection

The SRC will routinely review new intervention protocols submitted for full IRB review except the following:

  • Research approved for federal funding* (DoD, DoE, DoJ, EPA, HHS, AHRQ, CDC, FDA, NIH, etc.)
  • Research approved for corporation/foundation/organization/association funding utilizing an adequate peer review mechanism
  • Research that qualifies for expedited IRB review
  • Research that qualifies for exemption from IRB review

*This applies to secured federal funding only (documentation of scientific peer review will be requested at the time of pre-review)

The IRB and/or the Institutional Officials may, at their discretion, forward any protocol to the SRC at any point during the review process.

Elements of Scientific Review

The SRC protocol review form contains items that are considered by SRC reviewers when assessing the scientific rigor and merit of a study under review. However, not all items on the SRC protocol review form will apply to each protocol.

Membership

Chair

Gordon Huggins, MD
Investigator, Molecular Cardiology Research Institute Center for Translational Genomics
Cardiologist, Preventive Cardiology Center
Vice-Chair, Tufts Health Sciences Institutional Review Board
Associate Professor, Tufts University School of Medicine

Members

Ludovic Trinquart, PhD
Director of the Center for Clinical Trials at the Institute for Clinical Research and Health Policy Studies at Tufts CTSI
Associate Professor, Tufts University School of Medicine

Misha Eliasziw, PhD, MSc, HBSc
Associate Professor of Public Health and Community Medicine, Tufts University School of Medicine

Mabi Singh, DMD, MS
Associate Professor of Oral Medicine, Tufts University School of Dental Medicine
Director, Dry Mouth Clinic

MaryAnn Volpe, MD
Neonatologist
Associate Director, Newborn Medicine Fellowship Program
Chair, Tufts Health Sciences Institutional Review Board
Associate Professor, Tufts University School of Medicine

SRC Coordinator

Kimberly Garabedian
Kimberly.Garabedian@tuftsmedicine.org
(617) 636-7519